Characterization of methylthioadenosin phosphorylase (MTAP) expression in colorectal cancer

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–E386.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132.
   PubMed Web of Science ®Google Scholar
• Kleespies A, Fuessl KE, Seeliger H, et al. Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis. 2009;24:1097–1109.
   PubMed Web of Science ®Google Scholar
• Platell C, Ng S, O’Bichere A, et al. Changing management and survival in patients with stage IV colorectal cancer. Dis Colon Rectum. 2011;54:214–219.
   PubMed Web of Science ®Google Scholar
• Karoui M, Roudot-Thoraval F, Mesli F, et al. Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study. Dis Colon Rectum. 2011;54:930–938.
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008;9:102–114.
   PubMed Web of Science ®Google Scholar
• Bertino JR, Waud WR, Parker WB, et al. Targeting tumors that lack methylthioadenosine phosphorylase(MTAP) activity. Cancer Biol Ther. 2011;11:627–632.
   PubMed Web of Science ®Google Scholar
• Munshi PN, Lubin M, Bertino JR. 6-Thioguanine: a drug with unrealized potential for cancer therapy. Oncologist. 2014;19:760–765.
   PubMed Web of Science ®Google Scholar
• Kadariya Y, Yin B, Tang B, et al. Mice heterozygous for germ-line mutations in methylthioadenosine phosphorylase (MTAP) die prematurely of T-cell lymphoma. Cancer Res. 2009;69:5961–5969.
   PubMed Web of Science ®Google Scholar
• Efferth T, Miyachi H, Drexler HG, et al. Methylthioadenosine phosphorylase as target for chemoselective treatment of T-cell acute lymphoblastic leukemic cells. Blood Cells Mol Dis. 2002;28:47–56.
   PubMed Web of Science ®Google Scholar
• Izbicka E, Diaz A, Streeper R, et al. Distinct mechanistic activity profle of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancers. Cancer Chemother Pharmacol. 2009;64:993–999.
   PubMed Web of Science ®Google Scholar
• Tang B, Testa JR, Kruger WD. Increasing the therapeutic index of 5-fluorouracil and 6-thioguanine by targeting loss of MTAP in tumor cells. Cancer Biol Ther. 2012;13:1082–1090.
   PubMed Web of Science ®Google Scholar
• Tedeschi PM, Kathari YK, Farooqi IN, et al. Leucovorin rescue allows effective high-dose pralatrexate treatment and an increase in therapeutic index in mesothelioma xenografts. Cancer Chemother Pharmacol. 2014;4:93–99.
   Google Scholar
• Asselin BL, Devidas M, Wang C, et al. Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: a randomized study by the Children's Oncology Group (POG 9404)). Blood. 2011;118:874–883.
   PubMed Web of Science ®Google Scholar
• Ren MY, Wu XY. The research progress of toll-like receptors. Curr Immunol. 2006;26:340–342.
   Google Scholar
• Leal MF, Lima EM, Silva PN, et al. Promoter hypermethylation of CDH1, FHIT, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil. WJG. 2007;13:2568–2574.
   PubMed Web of Science ®Google Scholar
• Chow WA, Bedell V, Gaytan P, et al. Methylthioadenosine phosphorylase gene deletions are frequently detected by fluorescence in situ hybridization in conventional chondrosarcomas. Cancer Genet Cytogenet. 2006;166:95–100.
   PubMed Web of Science ®Google Scholar
• Hellerbrand C, Mühlbauer M, Wallner S, et al. Promoter hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma. Carcinogenesis. 2006;27:64–72.
   PubMed Web of Science ®Google Scholar
• Watanabe F, Takao M, Inoue K, et al. Immunohistochemical diagnosis of methylthioadenosine phosphorylase (MTAP) deficiency in non-small cell lung carcinoma. Lung Cancer. 2009;63:39–44.
   PubMed Web of Science ®Google Scholar
• Gurzu S, Silveanu C, Fetyko A, et al. Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer. World J Gastroenterol. 2016;22:6764–6775.
   PubMed Web of Science ®Google Scholar
• Wang EL, Qian ZR, Nakasono M, et al. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlate with poor prognosis in colorectal cancer. Br J Cancer. 2010;102:908–915.
   PubMed Web of Science ®Google Scholar
• Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006; 244:254–259.
   PubMed Web of Science ®Google Scholar